Likewise, as mentioned above in human patients and mouse models, prior studies evaluating the NF-λB/IL-6/STAT3 axis in other types of sarcoma have reported increased IL-6 signaling and attenuation of tumorigenesis following treatment with IL-6 inhibitors [28]. This evidence concerns the gene STAT3 and sarcoma.